The Andersons, Inc. heads into its Q1 earnings release today with a striking divergence: the stock has rallied 8% over the past month while the company's own chairman has been selling into every uptick.
Chairman Pat Bowe has sold shares on at least seven separate occasions since mid-March, unloading stock at prices ranging from $70.41 to $78.31. The total across those transactions runs to roughly $5.9 million. The sales have been consistent rather than concentrated — small tranches on most weeks, with larger blocks on April 6 and April 30. The pattern is notable not because any single sale is extraordinary, but because the selling has continued through the entire rally, right up to the day before tonight's earnings report.
The stock itself has held up well. ANDE closed at $79.29 on Tuesday, up 3.5% on the week and now trading above the Street's mean price target of $75. That premium to consensus is unusual for a mid-cap food distributor and reflects how much ground the stock has recovered since the tariff-driven selloff in early April. Close peers WMT and SYY gained 2.5% and lost 0.7% respectively on the week, so ANDE's outperformance is stock-specific rather than a sector tailwind.
The lending market tells a relaxed story. Short interest has fallen nearly 18% over the past month to 2.2% of the free float — shorts have been covering steadily into the same rally that Bowe has been selling into. Borrowing costs are minimal at 0.40%, and availability in the lending pool is extremely loose, far below the year's tightest readings. There is no meaningful squeeze pressure here. Options positioning has edged slightly more defensive over the past two weeks — the put/call ratio has climbed to 0.49 from a 20-day average of 0.38 — but the z-score of 0.79 puts that shift well within normal range. This is mild hedging into a known event, not a crowded bearish position.
The fundamental picture has been improving. ANDE ranks in the 85th percentile on both 30-day EPS momentum and forward EPS growth estimates, and in the 82nd percentile on earnings surprise history — suggesting the company has developed a habit of beating expectations. The dividend score comes in at the 90th percentile, reflecting a long record of consistent payouts. EV/EBITDA has eased slightly over the past month to 9.25x, a modest contraction as EBITDA estimates have risen faster than the enterprise value. The stock now running above analyst targets means the February upgrade from BMO Capital — which lifted the price objective from $65 to $75 while keeping an Outperform rating — has already been more than fully realised. The Street hasn't yet published updated targets reflecting the post-rally level.
The setup heading into tonight's release is therefore less about whether the fundamental story holds and more about what the chairman's persistent selling signals about the pace of recovery. Earnings reactions have been modest historically — the February 2026 print produced a 3.2% decline the next day — and with short sellers already having covered and the stock above all published price targets, the margin for a positive surprise to push shares meaningfully higher looks narrow.
See the live data behind this article on ORTEX.
Open ANDE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
